Medical Instruments & Supplies · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Orasure Technologies Inc publishes a filing, an earnings call transcript or a press release.
Get OSUR alertsKenneth McGrath is recorded as CFO at Orasure Technologies Inc (OSUR). The newest filing on record that lists Kenneth McGrath as CFO at Orasure Technologies Inc (OSUR) is dated April 30, 2026. The proxy statement of Orasure Technologies Inc reports total compensation of $1,316,208 for Kenneth McGrath in fiscal 2025, including a base salary of $512,000. Disclosed compensation is on record for 3 fiscal years. Kenneth McGrath has spoken on 5 earnings calls across 1 company, most recently for Orasure Technologies Inc on August 5, 2025. Orasure Technologies Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Orasure Technologies Inc includes Carrie Eglinton Manner (CEO and Board Member), Nancy Gagliano (CEO and Board Member), John P. Kenny (Chairman and Board Member) and 7 others.
“Total revenue in the second quarter was $31.2 million. Core revenue, which excludes COVID-19 products and the molecular services and risk assessment testing businesses that we exited was $30.8 million.”
“I'm happy to discuss our results for the third quarter of 2024 and provide updates on our financial outlook. In Q3, total revenue was $39.9 million. Core revenue, which excludes COVID-19 products and the molecular service business that we have exited, was $37.8 million.”
“I'm happy to discuss our results for the first quarter of 2024 and provide updates on our financial outlook. In Q1, we delivered total revenue of $54.1 million.”
“I'm happy to talk about our financial results for the fourth quarter and share updates on our financial outlook. First, we achieved total revenue of $123.1 million in the fourth quarter, marking another record for the company and representing year-over-year growth of 94%.”
“I'm pleased to discuss our financial results for the third quarter and provide updates on our financial outlook. First, from a topline perspective, we delivered total revenue of $116.5 million in the third quarter, which was another new record for the company, representing year-over-year growth of 116%.”
Start not stated–present
Last confirmed April 30, 2026
Medical Instruments & Supplies · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Orasure Technologies Inc (OSUR) | Chief Financial Officer | $512,000 | $1,316,208 |
| 2024 | Orasure Technologies Inc (OSUR) | Chief Financial Officer | $497,500 | $1,683,370 |
| 2023 | Orasure Technologies Inc (OSUR) | Chief Financial Officer | $483,000 | $1,528,599 |